Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure With Mid-range Ejection Fraction: a Multicentre Registry

NCT05167799 is registered in ClinicalTrials.gov with Ospedale C & G Mazzoni as lead sponsor.

NCT NCT05167799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05167799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure With Mid-range Ejection Fraction: a Multicentre Registry
Lead sponsor
Ospedale C & G Mazzoni
Phase
Observational
Overall status
Unknown status
Start date
May 13, 2021
Completion date
June 1, 2024
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis cardiac, heart failure